AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15543084 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% copper oxide ointment
Number of subjects: 61
Study 15543084 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% elementary copper ointment
Number of subjects: 61
Study 15543084 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 61
Study 14675923 — intervention group
Group type: EXPERIMENTAL
Intervention: ILC
Number of subjects: 31
Study 14675923 — intervention group
Group type: COMPARATOR
Intervention: TURP
Number of subjects: 31
Study 9647551 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (CPA) 25 mg/day plus testosterone enanthate (TE) 100 mg/week
Number of subjects: 10
Study 9647551 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (CPA) 12.5 mg/day plus testosterone enanthate (TE) 100 mg/week
Number of subjects: 10
Study 9647551 — intervention group
Group type: COMPARATOR
Intervention: Control phase (not specified)
Number of subjects: 10
Study 8086694 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral IgA‐IgG
Number of subjects: 200
Study 8086694 — intervention group
Group type: COMPARATOR
Intervention: Oral Gentamicin
Number of subjects: 200
Study 2722974 — intervention group
Group type: EXPERIMENTAL
Intervention: Brand A ranitidine tablets
Number of subjects: 10
Study 2722974 — intervention group
Group type: COMPARATOR
Intervention: Brand B ranitidine tablets
Number of subjects: 10
Study 9292 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprenolol 600 mg daily in divided doses for six weeks
Number of subjects: 16
Study 9292 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy for six weeks
Number of subjects: 16
Study 9292 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprenolol
Number of subjects: 16
Study 31549424 — intervention group
Group type: EXPERIMENTAL
Intervention: All-on-4 rehabilitation in the maxilla using at least two Zygoma implants (group 2)
Number of subjects: 70
Study 31549424 — intervention group
Group type: COMPARATOR
Intervention: All-on-4 rehabilitation in the maxilla (group 1)
Number of subjects: 70
Study 31549424 — intervention group
Group type: COMPARATOR
Intervention: All-on-4 rehabilitation in the mandible (group 3)
Number of subjects: 70
Study 31431779 — intervention group
Group type: COMPARATOR
Intervention: Aerobic interval training (AIT)
Number of subjects: 26
Study 31431779 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance interval training plus aerobic interval training (AIT)
Number of subjects: 26
Study 25905646 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory strategy training
Number of subjects: 0
Study 25905646 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive working memory practice
Number of subjects: 0
Study 25905646 — intervention group
Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 0
Study 25656375 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M+R (5ml solution containing 0.25% ropivacaine plus 5mg/kg magnesium sulphate)
Number of subjects: 61
Study 25656375 — intervention group
Group type: EXPERIMENTAL
Intervention: Group R (5ml 0.25% ropivacaine)
Number of subjects: 61
Study 25656375 — intervention group
Group type: COMPARATOR
Intervention: Group M (5ml solution containing 5mg/kg magnesium sulphate)
Number of subjects: 61
Study 25656375 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M+R
Number of subjects: 61
Study 25656375 — intervention group
Group type: EXPERIMENTAL
Intervention: Group R
Number of subjects: 61
Study 25656375 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M+R and Group R
Number of subjects: 61
Study 22933120 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operative hydrotubation (IH)
Number of subjects: 180
Study 22933120 — intervention group
Group type: COMPARATOR
Intervention: Post-operative hydrotubation (PH)
Number of subjects: 180
Study 22933120 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study 21556447 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular methyl prednisolone (40 mg) administered at two-week intervals, starting at the time of the procedure.
Number of subjects: 200
Study 21556447 — intervention group
Group type: COMPARATOR
Intervention: Usual preventive measures only (control group).
Number of subjects: 200
Study 19465192 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein concentrate (Resource Beneprotein Instant Protein Powder)
Number of subjects: 9
Study 19465192 — intervention group
Group type: COMPARATOR
Intervention: Fortified collagen protein hydrolysate (Pro‐Stat 101)
Number of subjects: 9
Study 17804844 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-chamber minimal ventricular pacing
Number of subjects: 1065
Study 17804844 — intervention group
Group type: COMPARATOR
Intervention: Conventional dual-chamber pacing
Number of subjects: 1065
Study 14998794 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11703562 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg melatonin at 18:00 hr
Number of subjects: 6
Study 11703562 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg melatonin at 20:00 hr
Number of subjects: 6
Study 11703562 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg melatonin at 21:00 hr
Number of subjects: 6
Study 11703562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 11703562 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg melatonin
Number of subjects: 6
Study 9502357 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity intervention
Number of subjects: 235
Study 9502357 — intervention group
Group type: COMPARATOR
Intervention: Structured exercise prescription
Number of subjects: 235
Study 7983648 — intervention group
Group type: EXPERIMENTAL
Intervention: SLE Disease Activity Index (SLEDAI)
Number of subjects: 8
Study 7983648 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic Lupus Activity Measure (SLAM)
Number of subjects: 8
Study 7983648 — intervention group
Group type: EXPERIMENTAL
Intervention: British Isles Lupus Assessment Group (BILAG)
Number of subjects: 8
Study 2596428 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola oil (CO) diet
Number of subjects: 0
Study 2596428 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower oil (SO) diet
Number of subjects: 0
Study 2596428 — intervention group
Group type: COMPARATOR
Intervention: Mixture of fats (MF) diet
Number of subjects: 0
Study 4080 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 20 mg t.d.s.
Number of subjects: 16
Study 4080 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg t.d.s.
Number of subjects: 16
Study 4080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31740724 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupants with obesity
Number of subjects: 13470
Study 30932957 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilities offering provider training in adolescent-friendly care
Number of subjects: 3662
Study 30932957 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilities using the Kenyan government's AYA care checklist
Number of subjects: 3662
Study 30932957 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilities where providers reported being trained in AYA HIV care
Number of subjects: 3662
Study 28242873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin (60 IU)
Number of subjects: 37
Study 28242873 — intervention group
Group type: COMPARATOR
Intervention: Placebo (8.7% sodium chloride)
Number of subjects: 37
Study 26493435 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin (MOX) therapy
Number of subjects: 40
Study 26493435 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing alone
Number of subjects: 40
Study 23775371 — intervention group
Group type: EXPERIMENTAL
Intervention: Social networking recruitment approach
Number of subjects: 609
Study 23775371 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone screening
Number of subjects: 609
Study 23775371 — intervention group
Group type: EXPERIMENTAL
Intervention: Health assessment screening
Number of subjects: 609
Study 23775371 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment process
Number of subjects: 609
Study 23775371 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of health assessment screening
Number of subjects: 609
Study 22117123 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized stress management intervention
Number of subjects: 60
Study 22117123 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 60
Study 19395710 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement educational program
Number of subjects: 47
Study 19395710 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study 16984588 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative proton pump inhibitor (PPI) administration for 1 week before EMR
Number of subjects: 0
Study 16984588 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic mucosal resection (EMR) without preoperative PPI administration
Number of subjects: 0
Study 16874155 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training programme (Group A)
Number of subjects: 44
Study 12969092 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 1085
Study 12969092 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole
Number of subjects: 1085
Study 12969092 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole
Number of subjects: 1085
Study 12969092 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole
Number of subjects: 1085
Study 10354241 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and structured assessment
Number of subjects: 39
Study 10354241 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 39
Study 7854524 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical AIDS group (n = 52)
Number of subjects: 138
Study 7854524 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4+ < 200/mm3 group (n = 57)
Number of subjects: 138
Study 7854524 — intervention group
Group type: COMPARATOR
Intervention: Dementia group (n = 29)
Number of subjects: 138
Study 7854524 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory neuropathy
Number of subjects: 138
Study 7854524 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy
Number of subjects: 138
Study 1742526 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissucol
Number of subjects: 39
Study 1742526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 7037868 — intervention group
Group type: EXPERIMENTAL
Intervention: Zomepirac sodium, 100 mg
Number of subjects: 40
Study 7037868 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone with APC (Percodan)
Number of subjects: 40
Study 7037868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 29287669 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab added to neoadjuvant carboplatin‐paclitaxel chemotherapy
Number of subjects: 0
Study 29287669 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant carboplatin‐paclitaxel chemotherapy without bevacizumab (implied control)
Number of subjects: 0
Study 30641618 — intervention group
Group type: EXPERIMENTAL
Intervention: Fangshuan Capsule (FC), 6 pills each time, three times per day for at least 2 days before PCI operation, therapeutic course of 2 weeks.
Number of subjects: 100
Study 30641618 — intervention group
Group type: EXPERIMENTAL
Intervention: Fangshuan Capsule (FC)
Number of subjects: 100
Study 30641618 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine Western medicine therapy only)
Number of subjects: 100
Study 25672179 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial nail avulsion with application of phenol
Number of subjects: 100
Study 25672179 — intervention group
Group type: COMPARATOR
Intervention: Partial nail avulsion alone
Number of subjects: 100
Study 24352000 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicultural education program
Number of subjects: 80
Study 24352000 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study 20438782 — intervention group
Group type: EXPERIMENTAL
Intervention: 25cL white wine (750kJ; approximately 26g alcohol)
Number of subjects: 22
Study 20438782 — intervention group
Group type: COMPARATOR
Intervention: Cake (750kJ)
Number of subjects: 22
Study 20438782 — intervention group
Group type: COMPARATOR
Intervention: 25cL water
Number of subjects: 22
Study 18801111 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 g/day maca
Number of subjects: 20
Study 18801111 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g/day maca
Number of subjects: 20
Study 18801111 — intervention group
Group type: EXPERIMENTAL
Intervention: Maca (both doses)
Number of subjects: 20
Study 16936236 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (400 mg/day orally)
Number of subjects: 16
Study 16936236 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) (400 mug/day inhalation)
Number of subjects: 16
Study 12969101 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous thoracic epidural analgesia (EDA)
Number of subjects: 50
Study 12969101 — intervention group
Group type: COMPARATOR
Intervention: Continuous intercostal (IC) block
Number of subjects: 50
Study 10939786 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril treatment for blood pressure reduction
Number of subjects: 0
Study 10939786 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 8967704 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL apheresis plus simvastatin, 40 mg/d
Number of subjects: 42
Study 8967704 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin, 40 mg/d
Number of subjects: 42
Study 1548923 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated equipment with low systemic heparinization (heparin 5000 IU) during left heart bypass or partial cardiopulmonary bypass
Number of subjects: 47
Study 1548923 — intervention group
Group type: COMPARATOR
Intervention: Low systemic heparinization (activated clotting time > 180 seconds)
Number of subjects: 47
Study 1548923 — intervention group
Group type: EXPERIMENTAL
Intervention: No systemic heparinization during cardiopulmonary bypass
Number of subjects: 47
Study 3933102 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocainide (250 mg, single i.v. dose)
Number of subjects: 10
Study 3933102 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (100 mg, single i.v. dose)
Number of subjects: 10
Study 28829923 — intervention group
Group type: EXPERIMENTAL
Intervention: High dairy intake (1500 mg calcium/day)
Number of subjects: 80
Study 28829923 — intervention group
Group type: COMPARATOR
Intervention: Low dairy intake (600 mg calcium/day)
Number of subjects: 80
Study 26460572 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT; Coping cat program)
Number of subjects: 488
Study 26460572 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (sertraline)
Number of subjects: 488
Study 26460572 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CBT and sertraline
Number of subjects: 488
Study 26460572 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 488
Study 25215530 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum 25(OH)D concentrations in women
Number of subjects: 5010
Study 25215530 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum 25(OH)D concentrations in men
Number of subjects: 5010
Study 22829794 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed appeals
Number of subjects: 4168
Study 22829794 — intervention group
Group type: COMPARATOR
Intervention: Loss-framed appeals
Number of subjects: 4168
Study 19780844 — intervention group
Group type: EXPERIMENTAL
Intervention: Denture adhesive used for 14 days
Number of subjects: 24
Study 19780844 — intervention group
Group type: COMPARATOR
Intervention: Control group (no denture adhesive)
Number of subjects: 24
Study 18364139 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 150
Study 18364139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 16103468 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin plus aspirin
Number of subjects: 5938
Study 16103468 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 5938
Study 12552048 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthetic applied on the contralateral forearm and foot
Number of subjects: 33
Study 12552048 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve function measurements (neuropathy disability score)
Number of subjects: 33
Study 12552048 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve function measurements (vibration perception threshold)
Number of subjects: 33
Study 12552048 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve function measurements (Semmes-Weinstein monofilament perception)
Number of subjects: 33
Study 10227572 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV screening using standard techniques
Number of subjects: 423
Study 10227572 — intervention group
Group type: EXPERIMENTAL
Intervention: History of previous transfusion
Number of subjects: 423
Study 8766067 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg clonidine
Number of subjects: 44
Study 8766067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 1822319 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuclopenthixol
Number of subjects: 15
Study 1822319 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 15
Study 7037325 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic methicillin
Number of subjects: 74
Study 7037325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 30760204 — intervention group
Group type: EXPERIMENTAL
Intervention: SENATOR software intervention
Number of subjects: 0
Study 30760204 — intervention group
Group type: COMPARATOR
Intervention: Standard routine pharmaceutical clinical care
Number of subjects: 0
Study 29465568 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to water sounds
Number of subjects: 60
Study 29465568 — intervention group
Group type: COMPARATOR
Intervention: Relaxing piece of music
Number of subjects: 60
Study 29465568 — intervention group
Group type: COMPARATOR
Intervention: No auditory stimulus
Number of subjects: 60
Study 26047827 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo pill
Number of subjects: 54
Study 26047827 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 54
Study 25193424 — intervention group
Group type: EXPERIMENTAL
Intervention: Online support tool (CHESS)
Number of subjects: 130
Study 25193424 — intervention group
Group type: COMPARATOR
Intervention: List of five commonly used Internet sites (comparison group)
Number of subjects: 130
Study 22460966 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g of valacyclovir twice daily for 1 year after initial treatment with 1 g of valacyclovir 3 times daily for 1 week
Number of subjects: 101
Study 22460966 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 20228387 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyspnoea relief
Number of subjects: 303
Study 20228387 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment success
Number of subjects: 303
Study 20228387 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate or marked improvement in dyspnoea
Number of subjects: 303
Study 20228387 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyspnoea relief and treatment success
Number of subjects: 303
Study 18005588 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (mean blood glucose 4.4 - 6.1 mmol/L)
Number of subjects: 188
Study 18005588 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (mean blood glucose 6.7 - 8.3 mmol/L)
Number of subjects: 188
Study 18005588 — intervention group
Group type: COMPARATOR
Intervention: Group C (mean blood glucose 10.0 - 11.1 mmol/L)
Number of subjects: 188
Study 16153516 — intervention group
Group type: EXPERIMENTAL
Intervention: ASD-D (atrial septal defect device closure) group
Number of subjects: 45
Study 16153516 — intervention group
Group type: EXPERIMENTAL
Intervention: ASD-S (atrial septal defect surgical closure) group
Number of subjects: 45
Study 16153516 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 11936456 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone scintigraphy using technetium diphosphonate 99 mTc
Number of subjects: 30
Study 11936456 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone scintigraphy
Number of subjects: 30
Study 10649937 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary toothbrush (Rota-dent)
Number of subjects: 40
Study 10649937 — intervention group
Group type: COMPARATOR
Intervention: Sonic toothbrush (Sonicare)
Number of subjects: 40
Study 8678619 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic J pouch anastomosis
Number of subjects: 100
Study 8678619 — intervention group
Group type: COMPARATOR
Intervention: Straight anastomosis
Number of subjects: 100
Study 1852517 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (200 micrograms, tidal breathing)
Number of subjects: 88
Study 1852517 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (200 micrograms, tidal breathing) after carbachol bronchial challenge
Number of subjects: 88
Study 1852517 — intervention group
Group type: COMPARATOR
Intervention: Placebo (phosphate-buffered saline)
Number of subjects: 88
Study 6338997 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acyclovir ointment
Number of subjects: 40
Study 6338997 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 40
Study 31025397 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 64
Study 31025397 — intervention group
Group type: COMPARATOR
Intervention: TENS
Number of subjects: 64
Study 29185897 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotropic medication with hypnotic effect (specific medications include mirtazapine and clotiapine)
Number of subjects: 481
Study 29185897 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine and clotiapine (hypnotic treatments)
Number of subjects: 481